Evidence map›Paper›PMID 21242892›Full record

ReviewCurrent opinion in HIV and AIDS2011

A simian immunodeficiency virus macaque model of highly active antiretroviral treatment: viral latency in the periphery and the central nervous system.

Janice E Clements, Lucio Gama, David R Graham, Joseph L Mankowski, M C Zink

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in HIV and AIDS, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Glutamine Antagonist JHU083 Normalizes Aberrant Glutamate Production and Cognitive Deficits in the EcoHIV Murine Model of HIV-Associated Neurocognitive Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2019
    Article
  12. Article
  13. Infectious Virus Persists in CD4Journal of virology · 2019
    Article
  14. A global scientific strategy to cure hepatitis B.The lancet. Gastroenterology & hepatology · 2019
    Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Janice E ClementsDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. jclements@jhmi.edu
Lucio Gama
David R Graham
Joseph L Mankowski
M C Zink
Johns Hopkins University · USJohns Hopkins Medicine · US

Funding

Project 4: Intracellular mechanism of virus persistence in astrocytes/macrophagesP01MH070306 · NIMH · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E · 2004 to 2015
$16.0M
Training Veterinarians for Careers in Biomedical ResearchT32RR007002 · NCRR · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 1985 to 2011
$4.4M
Minocycline Inhibits Immune Reactivation of CNS SIVR01NS055648 · NINDS · JOHNS HOPKINS UNIVERSITY · PI CLEMENTS, JANICE E · 2007 to 2011
$3.2M
Neuroprotective Effects of Minocycline in Lentiviral InfR01MH069116 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 2004 to 2008
$2.9M
IDO Regulation in the SIV Model of HIV CNS DiseaseR01MH085554 · NIMH · JOHNS HOPKINS UNIVERSITY · PI ZINK, M CHRISTINE · 2009 to 2013
$2.9M
NCRR NIH HHS RR07002NCRR NIH HHS T32 RR007002NIMH NIH HHS MH070306NIMH NIH HHS MH08554NIMH NIH HHS MH69116NIMH NIH HHS P01 MH070306NIMH NIH HHS R01 MH069116NIMH NIH HHS R01 MH085554NINDS NIH HHS NS055648NINDS NIH HHS R01 NS055648
6 · The paper itself

Abstract

purpose of reviewHere, simian immunodeficiency virus (SIV) macaque models are examined for their strengths in identifying in-vivo sites of HIV latency and persistent virus replication during highly active antiretroviral treatment (HAART). The best characterized HIV reservoir in HAART-treated persons is resting CD4 T cells in blood, although residual virus also comes from other reservoirs. Nonhuman primate/SIV models of HAART have been developed to characterize potential HIV reservoirs, particularly the central nervous system (CNS) and stem cells in bone marrow, known and potential reservoirs of latent virus that are difficult to study in humans. RECENT

findingsFew SIV macaque models of HAART have examined plasma and cerebrospinal fluid virus decay, the number of resting CD4 T cells harboring replication-competent latent SIV, HAART-treatment effect on the CNS, or residual viral replication or viral DNA levels in that tissue. Using a consistent, accelerated SIV macaque model, we characterized peripheral viral reservoirs, including those in the CNS, among HAART-treated macaques. The SIV model reproduces latency in memory CD4 T cells throughout the body and indicates that the CNS contains a stable SIV DNA reservoir. SUMMARY: An SIV macaque model of HAART recapitulating viral latency, particularly in the CNS, is required to study therapeutic approaches for a functional HIV cure.

Indexed as

Virus LatencyAnimalsBone MarrowCentral Nervous SystemDisease Models, AnimalHematopoietic Stem CellsHumansMacacaSimian Acquired Immunodeficiency SyndromeSimian Immunodeficiency Virus

Identifiers

PMID21242892
PMCPMC3215305
OpenAlexW1986079838

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.